Ventas Inc (VTR)vsChiron Real Estate Inc. (XRN)
VTR
Ventas Inc
$87.79
-0.26%
REAL ESTATE · Cap: $42.79B
XRN
Chiron Real Estate Inc.
$34.96
-1.44%
REAL ESTATE · Cap: $984.64M
Smart Verdict
WallStSmart Research — data-driven comparison
Ventas Inc generates 4029% more annual revenue ($6.11B vs $148.06M). VTR leads profitability with a 4.3% profit margin vs -3.9%. VTR appears more attractively valued with a PEG of 1.72. VTR earns a higher WallStSmart Score of 51/100 (C-).
VTR
Buy51
out of 100
Grade: C-
XRN
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+4.8%
Fair Value
$90.03
Current Price
$87.79
$2.24 discount
Intrinsic value data unavailable for XRN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 21.9% year-over-year
Reasonable price relative to book value
Strong operational efficiency at 25.1%
Areas to Watch
Expensive relative to growth rate
ROE of 2.1% — below average capital efficiency
4.3% margin — thin
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
Expensive relative to growth rate
ROE of -1.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : VTR
The strongest argument for VTR centers on Revenue Growth. Revenue growth of 21.9% demonstrates continued momentum.
Bull Case : XRN
The strongest argument for XRN centers on Price/Book, Operating Margin.
Bear Case : VTR
The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 160.0x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.
Bear Case : XRN
The primary concerns for XRN are EPS Growth, Market Cap, PEG Ratio.
Key Dynamics to Monitor
VTR profiles as a growth stock while XRN is a turnaround play — different risk/reward profiles.
XRN carries more volatility with a beta of 1.20 — expect wider price swings.
VTR is growing revenue faster at 21.9% — sustainability is the question.
XRN generates stronger free cash flow (18M), providing more financial flexibility.
Bottom Line
VTR scores higher overall (51/100 vs 41/100) and 21.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ventas Inc
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.
Chiron Real Estate Inc.
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Compare with Other REIT - HEALTHCARE FACILITIES Stocks
Want to dig deeper into these stocks?